A brand new research analyzing the immune response to COVID-19 in a Catalan cohort of well being employees sheds gentle on an vital query: does it matter whether or not an individual was first contaminated or first vaccinated?
Based on the outcomes, the order of the occasions does alter the result, at the very least with regards to long-term safety in opposition to omicron.
The research, revealed in Nature Communications, was led by the Barcelona Institute for World Well being (ISGlobal) in collaboration with the Catalan Well being Institute (ICS) and the Jordi Gol Institute (IDIAP JG), and with assist from the Daniel Bravo Andreu Personal Basis (FPDBA).
Because the begin of the pandemic, scientists have studied how the physique responds to SARS-CoV-2, specializing in antibodies and on T-cell responses. At this time, most individuals have what is named hybrid immunity, which means a mix of vaccination and an infection.
“Earlier research have proven that hybrid immunity offers stronger safety than both vaccination or an infection alone,” says ISGlobal researcher Carlota Dobaño, “however whether or not the order of those exposures affected the result remained an open query.”
A novel four-year dataset
The research was carried out amongst well being care professionals from ICS Central Catalonia, a bunch that was notably uncovered to SARS-CoV-2 all through the totally different waves of the pandemic.
The staff led by Dobaño analyzed blood samples collected repeatedly between 2020 and 2023 from 357 well being care professionals within the COVIDCatCentral cohort. Of those, 160 have been vaccinated earlier than turning into contaminated, whereas 197 have been contaminated first. Among the many latter, virtually all (98%) have been contaminated with the unique Wuhan variant.
“This long-term follow-up has made it attainable to construct a stable and extremely related database to research the immune response to COVID-19 over time,” says Anna Ruiz-Comellas, a researcher at ICS–IDIAP Jordi Gol who led the fieldwork.
Due to common serological testing, it was attainable to detect each symptomatic and asymptomatic infections. The staff assessed antibody and T-cell responses to 5 totally different viral antigens.
Stronger antibodies to omicron in these vaccinated first
The research discovered that, in comparison with these initially contaminated, individuals who have been first uncovered to SARS-CoV-2 via vaccination developed greater ranges of IgG and IgA antibodies in opposition to six omicron lineages (notably, to the receptor binding area of the spike protein). This distinction grew to become smaller as people accrued extra exposures to the virus.
“In distinction, these contaminated first mounted a considerably stronger T-cell response, which can consequence from being uncovered to a wider repertoire of antigens or greater viral hundreds,” says ISGlobal researcher and senior co-author Gemma Moncunill . Nonetheless, the authors be aware that the variety of members evaluated for T-cell immunity was restricted, so these outcomes must be interpreted with warning.
Antibody dynamics replicate medical safety
These antibody variations have been mirrored in medical safety over time. Folks contaminated first have been higher protected early within the pandemic, when variants have been nearer to the unique pressure. However with the arrival of omicron, the benefit shifted: these vaccinated first have been higher protected against breakthrough infections.
“Our outcomes present new proof that first publicity to SARS-CoV-2 antigens by way of vaccination strengthens the long-term protecting impact of hybrid immunity,” says Otavio Ranzani, first writer of the research.
General, the research highlights the function of the vaccination campaigns in opposition to SARS-CoV-2 by serving to form a powerful immune response as new variants emerge.
This research is a part of the END-VOC mission, which goals to assist the response to COVID-19 and different pandemics.
Extra data
Otavio Ranzani et al, Main SARS-CoV-2 publicity by vaccination or an infection shapes immune responses to omicron variants amongst a Spanish cohort, Nature Communications (2025). DOI: 10.1038/s41467-025-67577-9
Journal data: Nature Communications
